Jerry Pelletier

37.4k total citations · 14 hit papers
318 papers, 28.6k citations indexed

About

Jerry Pelletier is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Immunology. According to data from OpenAlex, Jerry Pelletier has authored 318 papers receiving a total of 28.6k indexed citations (citations by other indexed papers that have themselves been cited), including 284 papers in Molecular Biology, 35 papers in Cardiology and Cardiovascular Medicine and 27 papers in Immunology. Recurrent topics in Jerry Pelletier's work include RNA and protein synthesis mechanisms (90 papers), RNA Research and Splicing (58 papers) and PI3K/AKT/mTOR signaling in cancer (55 papers). Jerry Pelletier is often cited by papers focused on RNA and protein synthesis mechanisms (90 papers), RNA Research and Splicing (58 papers) and PI3K/AKT/mTOR signaling in cancer (55 papers). Jerry Pelletier collaborates with scholars based in Canada, United States and Germany. Jerry Pelletier's co-authors include Nahum Sonenberg, David E. Housman, Alan Buckler, Françis Robert, Daniel A. Haber, Regina Cencic, Katherine M. Call, Abba Malina, Scott W. Lowe and Jordan A. Kreidberg and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Jerry Pelletier

316 papers receiving 28.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus

1990 1.6k citations Jerry Pelletier, David E. Housman et al. profile →
Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA

1988 1.6k citations Jerry Pelletier, Nahum Sonenberg profile →
WT-1 is required for early kidney development

1993 1.5k citations Jerry Pelletier, David E. Housman et al. profile →
Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy

2004 794 citations Jerry Pelletier et al. profile →
Target identification using drug affinity responsive target stability (DARTS)

2009 785 citations Jerry Pelletier et al. Proceedings of the National Academy of Sciences profile →
The candidate Wilms' tumour gene is involved in genitourinary development

1990 718 citations Jerry Pelletier, David E. Housman et al. profile →
Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome

1991 716 citations Jerry Pelletier et al. profile →
Targeting the translation machinery in cancer

2015 597 citations Nahum Sonenberg, Jerry Pelletier et al. profile →
Insertion mutagenesis to increase secondary structure within the 5′ noncoding region of a eukaryotic mRNA reduces translational efficiency

1985 555 citations Jerry Pelletier, Nahum Sonenberg profile →
Short RNAs Repress Translation after Initiation in Mammalian Cells

2006 533 citations Jerry Pelletier et al. profile →
Statistical practice in high-throughput screening data analysis

2006 527 citations Jerry Pelletier et al. profile →
Alternative splicing and genomic structure of the Wilms tumor gene WT1.

1991 512 citations Jerry Pelletier, David E. Housman et al. Proceedings of the National Academy of Sciences profile →
The Energy Sensor AMPK Regulates T Cell Metabolic Adaptation and Effector Responses In Vivo

2015 501 citations Gabriela Galicia-Vázquez, Jerry Pelletier et al. profile →
An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor

1990 478 citations Jerry Pelletier, David E. Housman et al. profile →

Peers

Countries citing papers authored by Jerry Pelletier

Since Specialization

Citations

This map shows the geographic impact of Jerry Pelletier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerry Pelletier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerry Pelletier more than expected).

Fields of papers citing papers by Jerry Pelletier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jerry Pelletier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerry Pelletier. The network helps show where Jerry Pelletier may publish in the future.

Co-authorship network of co-authors of Jerry Pelletier

This figure shows the co-authorship network connecting the top 25 collaborators of Jerry Pelletier. A scholar is included among the top collaborators of Jerry Pelletier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jerry Pelletier. Jerry Pelletier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Identification of Rocaglate Acyl Sulfamides as Selective Inhibitors of Glioblastoma Stem Cells 2024 ·ACS Central Science ·(unknown), Ritesh Thakare, (unknown), Alok Mishra, (unknown), (unknown), (unknown), Lihua Julie Zhu, Lauren E. Brown, Regina Cencic, Sidong Huang, M R Green, Jerry Pelletier, Sunil K. Malonia, John A. Porco	2
2	Amidino-rocaglates (ADRs), a class of synthetic rocaglates, are potent inhibitors of SARS-CoV-2 replication through inhibition of viral protein synthesis 2024 ·Antiviral Research ·(unknown), Wenhan Zhang, (unknown), (unknown), (unknown), Regina Cencic, J. J. Patten, (unknown), Elias Carvalho Padilha, John H. Connor, Jerry Pelletier, Shawn M. Lyons, Mohsan Saeed, Lauren E. Brown, John A. Porco, Robert A. Davey	2
3	A second-generation eIF4A RNA helicase inhibitor exploits translational reprogramming as a vulnerability in triple-negative breast cancer 2024 ·Proceedings of the National Academy of Sciences ·Regina Cencic, (unknown), (unknown), (unknown), (unknown), (unknown), Matthew G. Annis, Françis Robert, T.M. Schmeing, Antonis E. Koromilas, Marilène Paquet, Jose G. Teodoro, Sidong Huang, Peter M. Siegel, Ivan Topisirović, Josie Ursini‐Siegel, Jerry Pelletier	13
4	Inhibition of the Translation Initiation Factor eIF4A Enhances Tumor Cell Radiosensitivity 2022 ·Molecular Cancer Therapeutics ·Stacey L. Lehman, (unknown), (unknown), Lauren E. Brown, John A. Porco, William G. Devine, Jerry Pelletier, Uma Shankavaram, Kevin Camphausen, Philip J. Tofilon	4
5	Functional mimicry revealed by the crystal structure of an eIF4A:RNA complex bound to the interfacial inhibitor, desmethyl pateamine A 2021 ·Cell chemical biology ·(unknown), (unknown), Kenneth G. Hull, Regina Cencic, Mingzhao Zhu, Peter T. Northcote, Paul Teesdale‐Spittle, Daniel Romo, Bhushan Nagar, Jerry Pelletier	26
6	Eukaryotic Translation Initiation Factor 4AI: A Potential Novel Target in Neuroblastoma 2021 ·Cells ·(unknown), (unknown), Stefanie Krassnig, Anna Maria Birkl-Toeglhofer, Georg Singer, Holger Till, Martin Benesch, Regina Cencic, John A. Porco, Jerry Pelletier, Christoph Castellani, (unknown), Ewa Iżycka‐Świeszewska, Piotr Czapiewski, Johannes Haybaeck	12
7	TACIMA-218: A Novel Pro-Oxidant Agent Exhibiting Selective Antitumoral Activity 2020 ·Molecular Cancer Therapeutics ·Jamilah Abusarah, (unknown), Nehmé El-Hachem, Abed El-Hakim El-Kadiry, Ian Hammond-Martel, Hugo Würtele, (unknown), Noël J.‐M. Raynal, Françis Robert, Jerry Pelletier, Maja Jankovic, François Mercier, (unknown), Borhane Annabi, Moutih Rafei	4
8	The mTORC1/S6K/PDCD4/eIF4A Axis Determines Outcome of Mitotic Arrest 2020 ·Cell Reports ·(unknown), (unknown), Wissal El-Assaad, Y.M. Abbas, Valentina Gandin, Bhushan Nagar, Jerry Pelletier, Ivan Topisirović, Jose G. Teodoro	25
9	eIF4A Inhibitors Suppress Cell-Cycle Feedback Response and Acquired Resistance to CDK4/6 Inhibition in Cancer 2019 ·Molecular Cancer Therapeutics ·Tim Kong, Yibo Xue, Regina Cencic, Xianbing Zhu, Anie Monast, Zheng Qing Fu, (unknown), Veena Sangwan, Marie‐Christine Guiot, William D. Foulkes, John A. Porco, Morag Park, Jerry Pelletier, Sidong Huang	33
10	Intercepted Retro-Nazarov Reaction: Syntheses of Amidino-Rocaglate Derivatives and Their Biological Evaluation as eIF4A Inhibitors 2019 ·Journal of the American Chemical Society ·Wenhan Zhang, Jennifer Chu, (unknown), (unknown), Lauren E. Brown, Tony T. Wang, Jerry Pelletier, John A. Porco	26
11	Magnesium-sensitive upstream ORF controls PRL phosphatase expression to mediate energy metabolism 2019 ·Proceedings of the National Academy of Sciences ·Serge Hardy, Elie Kostantin, (unknown), (unknown), Gabriela Galicia-Vázquez, Pavel V. Baranov, Jerry Pelletier, Michel L. Tremblay	41
12	A New Benzopyranyl Cadenane Sesquiterpene and Other Antiplasmodial and Cytotoxic Metabolites from Cleistochlamys kirkii 2019 ·Molecules ·Stephen S. Nyandoro, (unknown), Joan J. E. Munissi, (unknown), Paul Fitzpatrick, Sofia Lindblad, Sandra Duffy, Jerry Pelletier, Fangfang Pan, Rakesh Puttreddy, Vicky M. Avery, Máté Erdélyi	13
13	TC-PTP regulates the IL-7 transcriptional response during murine early T cell development 2017 ·Scientific Reports ·Kelly A. Pike, (unknown), (unknown), Françis Robert, (unknown), Diego Miranda‐Saavedra, Jerry Pelletier, Michel L. Tremblay	12
14	Targeting Protein Synthesis in a Myc/mTOR-Driven Model of Anorexia-Cachexia Syndrome Delays Its Onset and Prolongs Survival 2011 ·Cancer Research ·Françis Robert, John R. Mills, (unknown), Dantong Wang, Sergio Di Marco, Regina Cencic, Michel L. Tremblay, Imed‐Eddine Gallouzi, Siegfried Hekimi, Simon S. Wing, Jerry Pelletier	30
15	The Antidepressant Sertraline Inhibits Translation Initiation by Curtailing Mammalian Target of Rapamycin Signaling 2010 ·Cancer Research ·Chen‐Ju Lin, Françis Robert, Rami Sukarieh, Stephen W. Michnick, Jerry Pelletier	54
16	Silibinin inhibits translation initiation: implications for anticancer therapy 2009 ·Molecular Cancer Therapeutics ·Chen‐Ju Lin, Rami Sukarieh, Jerry Pelletier	36
17	c-Myc and eIF4F Are Components of a Feedforward Loop that Links Transcription and Translation 2008 ·Cancer Research ·Chen‐Ju Lin, Regina Cencic, John R. Mills, Françis Robert, Jerry Pelletier	130
18	Stimulation of mammalian translation initiation factor eIF4A activity by a small molecule inhibitor of eukaryotic translation 2005 ·Proceedings of the National Academy of Sciences ·(unknown), James Matthews, (unknown), Lisa Lindqvist, Olivia Novac, Eckhard Jankowsky, Nahum Sonenberg, Peter T. Northcote, Paul Teesdale‐Spittle, Jerry Pelletier	180
19	Sequence and structural requirements for high-affinity DNA binding by the WT1 gene product 1995 ·Molecular and Cellular Biology ·Hitoshi Nakagama, Günther Heinrich, Jerry Pelletier, David E. Housman	145
20	An Efficient Strategy To Isolate Full-Length cDNAs Based on an mRNA Cap Retention Procedure (CAPture) 1995 ·Molecular and Cellular Biology ·Isaac Edery, Lee Lee Chu, Nahum Sonenberg, Jerry Pelletier	75

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact